Cargando…
Neuronal Cannabinoid CB(1) Receptors Suppress the Growth of Melanoma Brain Metastases by Inhibiting Glutamatergic Signalling
SIMPLE SUMMARY: An estimated 60% of melanoma patients develop melanoma brain metastases (MBMs). However, the molecular factors that govern the growth of MBMs are still unknown. The excitatory neurotransmitter glutamate has been shown to control the proliferation of various types of cancer cells with...
Autores principales: | Costas-Insua, Carlos, Seijo-Vila, Marta, Blázquez, Cristina, Blasco-Benito, Sandra, Rodríguez-Baena, Francisco Javier, Marsicano, Giovanni, Pérez-Gómez, Eduardo, Sánchez, Cristina, Sánchez-Laorden, Berta, Guzmán, Manuel |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10177062/ https://www.ncbi.nlm.nih.gov/pubmed/37173906 http://dx.doi.org/10.3390/cancers15092439 |
Ejemplares similares
-
GABAergic and Cortical and Subcortical Glutamatergic Axon Terminals Contain CB(1) Cannabinoid Receptors in the Ventromedial Nucleus of the Hypothalamus
por: Reguero, Leire, et al.
Publicado: (2011) -
Dichotomic Hippocampal Transcriptome After Glutamatergic vs. GABAergic Deletion of the Cannabinoid CB1 Receptor
por: Pascual Cuadrado, Diego, et al.
Publicado: (2021) -
The cannabinoid receptor 1 associates with NMDA receptors to produce glutamatergic hypofunction: implications in psychosis and schizophrenia
por: Sánchez-Blázquez, Pilar, et al.
Publicado: (2014) -
Cannabinoid CB1 receptor in dorsal telencephalic glutamatergic neurons drives overconsumption of palatable food and obesity
por: Ruiz de Azua, Inigo, et al.
Publicado: (2021) -
Identification of BiP as a CB(1) Receptor-Interacting Protein That Fine-Tunes Cannabinoid Signaling in the Mouse Brain
por: Costas-Insua, Carlos, et al.
Publicado: (2021)